Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹71.80
Market cap
₹18.09 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.5×Sector 47.4×
Promoter holding
50.60%-15.40% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:39 IST BSE
Annual General Meeting

Colinz Laboratories Annual General Meeting

Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.

19:34 IST BSE
Open Offer

Colinz Laboratories Open Offer: ₹3.54 Cr

Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.

Value
₹3.54 Cr
15:26 IST BSE
Annual Report

Colinz Laboratories Annual Report

Colinz Laboratories Limited has submitted its 40th Annual Report for the financial year 2025-26. The report includes notice for the Annual General Meeting scheduled for September 22, 2026.

14:48 IST BSE
Annual General Meeting

Colinz Laboratories Annual General Meeting

Colinz Laboratories Ltd has issued the notice for its 40th Annual General Meeting scheduled for September 22, 2026. The agenda includes director re-appointments and auditor report adoption.

18:19 IST BSE
Open Offer

Colinz Laboratories Open Offer: ₹3.54 Cr

Saffron Capital Advisors filed a reminder advertisement for the open offer of Colinz Laboratories. The offer seeks to acquire up to 26% stake for ₹3.54 Crore.

Value
₹3.54 Cr